First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer
Clinical trial NCT06253611 · RECRUITING
Trial details
- NCT number
- NCT06253611
- Sponsor
- GERCOR - Multidisciplinary Oncology Cooperative Group
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-16
- Primary completion
- 2027-09-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.